Cefprozil · CEFPROZIL 500 mg/1 · Tablet, Film Coated · Oral · Rising Pharma Holdings, Inc.
NDC 57237-0037-01 · 100 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →
6 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 27% over the past year, to $1.15 per unit.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Aurobindo Pharma Limited | CEFPROZIL 250 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aurobindo Pharma Limited | CEFPROZIL 500 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| A-S Medication Solutions | CEFPROZIL 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ascend Laboratories, LLC | CEFPROZIL 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ascend Laboratories, LLC | CEFPROZIL 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar Rx LLC | CEFPROZIL 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| NorthStar Rx LLC | CEFPROZIL 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | CEFPROZIL 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | CEFPROZIL 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | CEFPROZIL 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Teva Pharmaceuticals USA, Inc. | CEFPROZIL 250 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Cefprozil — NDC 57237-0037-01," retrieved September 3, 2026, https://drugdashboards.com/drug/57237003701.
Free to cite with attribution — see how the data is put together.